Literature DB >> 17195148

Prognostic factors and clinical features in liveborn neonates with hydrops fetalis.

Hsuan-Rong Huang1, Pei-Kwei Tsay, Ming-Chou Chiang, Reyin Lien, Yi-Hung Chou.   

Abstract

The purpose of this study was to delineate the etiology and the clinical features of liveborn neonates with hydrops fetalis, and to explore the prognostic factors for survival. Medical records of 28 liveborn neonates with hydrops fetalis between April 1995 and March 2005 were reviewed retrospectively. Demographic data, clinical manifestations, laboratory findings, and outcomes were analyzed. Most patients presented with pleural effusions (21 of 28) and ascites (22 of 28). The majority of patients had hydrops due to cardiovascular diseases (seven of 28), hematologic disorders (six of 28), lymphatic malformations (six of 28), and idiopathic origins (six of 28). The overall survival rate was 50% and was highest (83%) in infants with lymphatic malformations. By univariate analysis, risk factors for mortality are earlier ages at diagnosis and at birth, low Apgar scores, need for resuscitation in the delivery room, low serum albumin level, and severe acidemia. After using stepwise multiple logistic regression analysis, the most significant factors associated with fatality were younger gestational age at birth and lower serum albumin level. Hydrops fetalis remains a complex condition with a high mortality rate. Hydrops resulting from lymphatic malformations has a favorable outcome. Preterm birth at less than 34 weeks and serum albumin concentration lower than 2 g/dL are two poor prognostic factors for survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17195148     DOI: 10.1055/s-2006-958158

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  8 in total

1.  Prenatal factors associated with neonatal survival of infants with congenital chylothorax.

Authors:  M Dorsi; A Giuseppi; F Lesage; J Stirnemann; L De Saint Blanquat; M Nicloux; Z Assaf; N Khen Dunlop; E Kermorvant-Duchemin; J-F Magny; Y Ville; A Lapillonne
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

2.  The many faces of hydrops.

Authors:  S Christopher Derderian; Cerine Jeanty; Shannon R Fleck; Lily S Cheng; Shabnam Peyvandi; Anita J Moon-Grady; Jody Farrell; Shinjiro Hirose; Juan Gonzalez; Roberta L Keller; Tippi C MacKenzie
Journal:  J Pediatr Surg       Date:  2014-10-29       Impact factor: 2.545

3.  Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases.

Authors:  Dahua Meng; Qifei Li; Xuehua Hu; Lifang Wang; Shuyin Tan; Jiasun Su; Yue Zhang; Weijia Sun; Biyan Chen; Sheng He; Fei Lin; Bobo Xie; Shaoke Chen; Pankaj B Agrawal; Shiyu Luo; Chunyun Fu
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

4.  Frequency and Prognosis of Hydrops Fetalis: A 10-Year Single-Center Experience.

Authors:  Ebru Turkoglu Unal; Ali Bulbul; Evrim Kiray Bas; Hasan Sinan Uslu
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

5.  Survival of Hydrops Fetalis with and without Fetal Intervention.

Authors:  Yu-Yun Huang; Yu-Jun Chang; Lih-Ju Chen; Cheng-Han Lee; Hsiao-Neng Chen; Jia-Yuh Chen; Ming Chen; Chien-Chou Hsiao
Journal:  Children (Basel)       Date:  2022-04-08

6.  Fetal Distress and Neonatal Death After Thoracoamniotic Shunting Therapy Due to Hydrops Associated With Transient Abnormal Myelopoiesis.

Authors:  Junsuke Muraoka; Nozomi Yoshimoto; Ayako Ohsawa; Satoshi Matsuzawa; Shinji Katsuragi
Journal:  Cureus       Date:  2022-09-09

Review 7.  Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature.

Authors:  Catharina Whybra; Eugen Mengel; Alexandra Russo; Franz Bahlmann; Christoph Kampmann; Michael Beck; Elke Eich; Eva Mildenberger
Journal:  Orphanet J Rare Dis       Date:  2012-11-08       Impact factor: 4.123

8.  Hydrops fetalis with isolated massive ascites in a preterm neonate with rhesus disease.

Authors:  Nasenien Nourkami-Tutdibi; Martina Geipel; Gabriele Meyberg-Solomayer; Zoltan Takacs; Sascha Meyer
Journal:  Wien Med Wochenschr       Date:  2021-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.